![](/img/cover-not-exists.png)
The characteristics and outcomes of patients with multiple myeloma dual refractory or intolerant to bortezomib and lenalidomide in the era of carfilzomib and pomalidomide
Wang, Tzu-Fei, Ahluwalia, Rohan, Fiala, Mark A., Trinkaus, Kathryn M., Cox, Doug P., Jaenicke, Matthew, Moliske, Caitlin C., Carson, Kenneth R., Wildes, Tanya M., Tomasson, Michael H., Stockerl-GoldstVolume:
55
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2013.803547
Date:
February, 2014
File:
PDF, 209 KB
english, 2014